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Abstract 
 
Background:  The study aim was to establish and quantify suicide risk following acute 
admissions for all major physical illnesses, for confirmatory purposes, from two independent 
information sources from different countries.  
 
Methods:    Record linkage of inpatient and death certificate data for 11,004,389 acute 
admissions for physical illnesses in England and 713,496 in Wales. The main outcome measure 
was standardised mortality ratios (SMRs) for suicide at one year following discharge from 
hospital. 
 
Results:   There were 1,781 suicides within one year of discharge in England (SMR=1.7; 95% = 
1.6-1.8) and 131 in Wales (SMR=2.0; 1.7-2.0). Of 48 major physical illnesses that were 
associated with at least eight suicides in either country, there was high consistent suicide 
mortality (significant SMR >3) in both countries for constipation (SMR=4.1 in England, 7.5 in 
Wales), gastritis (4.4 and 4.9) and upper gastrointestinal bleeding (3.4 and 4.5). There was high 
suicide mortality in one country for alcoholic liver disease, other liver disease and chronic 
pancreatitis; for epilepsy and Parkinson's disease; for diabetes, hypoglycaemia and hypo-
osmolality & hyponatraemia; and for pneumonia, back pain and urinary tract infections.  
 
Conclusions:    There is little or no increased suicide mortality following acute admissions for 
most physical illnesses. Much of the increased suicide mortality relates to gastrointestinal 
disorders that are often alcohol related or specific chronic conditions which may be linked to 
side effects from certain therapeutic medications. Acute hospital admissions for physical 
illnesses may therefore provide an opportunity for targeted suicide prevention among people 
with certain conditions, particularly alcohol related disorders.  
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Introduction 
 
Globally, suicide is a major public health issue with 800,000 deaths every year (World Health 
Organisation, 2017). Premature loss of life in early and mid-adulthood also makes suicide an 
important global cause of years of healthy life lost (Lozano et al, 2013). In the UK, there are 
approximately 6,000 suicides annually, of which approximately 25% occur within one year of an 
acute hospital admission (Office for National Statistics, 2014; study data). 
 
Established risk factors for suicide include mental disorders such as depression, anxiety and 
bipolar disorder, as well as alcohol and substance misuse disorders (Newman & Bland, 1991; 
Angst et al. 2005; Merrall et al. 2012). Previous studies of physical illnesses and suicide have 
been confined mostly to single disorders rather than looking more broadly at the overall 
relationship. Increased suicide rates have been established for conditions including epilepsy 
(Hawton et al. 1980; Bell et al. 2009; Singhal et al. 2014; Erlangsen et al. 2015), type I diabetes 
(Kyvik et al. 1994; Singhal et al. 2014; Erlangsen et al. 2015), multiple sclerosis (Harris & 
Barraclough, 1994; Manouchehrinia et al. 2016), cancers (Harris & Barraclough, 1994; Druss & 
Pincus, 2000; Crump et al. 2014; Erlangsen et al. 2015), and asthma (Crump et al. 2014; Barker 
et al. 2015), although little has been reported for many other physical illnesses. 
 
Studies that have reported on associations between suicide and a wide range of physical 
illnesses include cohort studies, based mostly in the community (Webb et al. 2012; Crump et al. 
2014; Erlangsen et al. 2015), rather than in hospital settings (Qin et al. 2016), and largely from 
Scandinavia (Crump et al. 2014; Erlangsen et al. 2015; Qin et al. 2016); or based on review 
methodology (Harris & Barraclough, 1994) with varying methods used across the reports 
included. A recent study found that those who died by suicide were more frequently discharged 
from general rather than psychiatric hospitals (Dougall et al. 2014). While this study highlighted 
that engaging in suicide prevention within the general hospital setting deserves more attention, 
other than for self harm, it provided little evidence for where these efforts should be focussed. 
Information on increased risks of suicide among people hospitalised acutely for physical 
illnesses has not been reported previously and could be useful for suicide prevention purposes 
and for raising clinical awareness, especially as longer duration contacts with health services 
provide opportunities for interventions to reduce suicide risks.  
 
The aim of the study was to establish and quantify any increased or decreased risks of suicide 
following acute inpatient admissions for all major physical illnesses. Importantly, to provide 
confirmatory evidence, the study was based on two corresponding but independent hospital 
information sources from two neighbouring countries. The main study hypothesis was that 
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most physical illnesses with previously established links with suicide would also be associated 
in this study, along with some alcohol-related disorders that have not been reported previously.  
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Method 
 
Study population 
A retrospective cohort design was used for people in England (population 53.5 million in 2012) 
and Wales (3.0 million) who were hospitalised as emergencies. The study was based on national 
administrative inpatient data; Hospital Episode Statistics in England and the corresponding 
Patient Episode Database for Wales. The inpatient data were systematically linked to mortality 
data from the Office for National Statistics and the Welsh Demographic Service to identify all 
suicides that occurred up to one year following discharge from hospital. The data were 
compiled and accessed through the Secure Anonymised Information Linkage (SAIL) databank 
(Lyons et al. 2009), by a team from the Farr Institute of Health Informatics Research. The 
ascertainment of mortality has been validated as >98% accurate and the record linkage 
methodology, based on a unique anonymised, encrypted linking field for each patient, as 
>99.8% accurate (Lyons et al. 2009).  
 
The study population included adults aged 18 years or over, who had an unscheduled admission 
to any public hospital in England or Wales from January 1st 2004 to December 31st 2011. We 
included each person’s first emergency admission during the study period and followed them 
up in order to establish all suicides within one year of discharge from hospital. Subsequent 
admissions during the study period were similarly included for one year follow-up provided 
they occurred at least one year after hospital discharge from the preceding admission and that 
the discharge date occurred at least one year before the end of the study period. Our study 
cohorts should not be affected substantially by attrition over the one-year follow-up period, as 
annual population emigration from both England and Wales was less than 2.8% annually during 
the study period (Office for National Statistics; Welsh Assembly Government).  
 
 
Physical illnesses  
As the focus of the study was on physical rather than mental illnesses, we studied all physical 
illnesses (ICD-10 codes A00-E99, G01-Q99), based on the principal diagnosis at discharge, 
excluding mental and behavioural disorders. We included all 'major' physical illnesses that led 
to at least eight suicides within one year of discharge from hospital in either England or Wales. 
48 physical illnesses fulfilled these inclusion and exclusion criteria. ICD-10 codes for each 
disease are listed in Appendix 1. 
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Study outcome measures  
The main study outcome measure was the standardised mortality ratio (SMR) to assess suicide 
mortality up to one year following hospital discharge in the study cohorts compared with that in 
the corresponding general population. Suicide was defined by intentional self harm (ICD-10 
codes X60-X84) or undetermined intent (Y10-Y33.8) when recorded as the underlying cause of 
death on death certificates. Deaths coded as Y33.9 (pending verdicts) were excluded, as a large 
proportion of these deaths are subsequently determined to be homicides (Griffiths et al. 2005).  
 
 
Methods of analysis 
Age and sex adjusted SMRs for suicide were calculated using the indirect method and by 
applying age and sex specific suicide mortality in the general adult population of England of 
Wales to obtain the expected suicides in the study populations and by then comparing the 
observed and expected suicides. The age groups used were 18-19 years, 20-24 quinquennially 
up to 80-84 and then 85+ years. For each of the 48 physical illnesses, age and sex were missing 
in <0.01% of cases and with no impact on the SMRs, missing data were excluded from the 
analysis. A sensitivity analysis was carried out by confining the study to the first admission for 
each patient during the study period. 
 
Statistical significance was measured at the conventional 5% level. However, as this is affected 
by the differing sizes of the two study populations and the numbers of suicides, we arbitrarily 
defined suicide mortality following physical illnesses as “high mortality" or "high risk” for a 
statistically significant increased SMR >3, and as “increased mortality” or “increased risk” for a 
significantly increased SMR of between one and 3.  
 
For physical illnesses with high suicide mortality, we investigated the extent to which the 
suicides risks were mediated by ‘pre-existing mental illness’. This was defined using mental and 
behavioural disorders recorded in any position on the patients’ current inpatient records or 
from any previous acute admissions during the nine year study period (see Appendix for these 
disorders and ICD-10 codes). 
 
Logistic regression modelling was used to assess changes in suicide odds ratios for each 
physical illness, firstly, after adjusting for pre-existing mental illness, patient age and sex 
(models 2) compared with age and sex alone (models 1). Secondly, after adjusting for pre-
existing mental illness, year of discharge, social deprivation, age and sex (models 3) compared 
with age and sex (models 1). Social deprivation was measured in quintiles, based on the widely 
used English Indices of Deprivation (Office for National Statistics, 2007) and corresponding 
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Welsh Index of Multiple Deprivation (Welsh Assembly Government, 2008). The chi-squared test 
was used to compare major categories of physical illnesses (circulatory, respiratory, 
gastrointestinal and all other) that were associated with suicide and emergency admissions 
respectively.  
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Results 
 
During the study period there were 11,004,389 acute admissions for physical illnesses across 
England and 713,496 across Wales, as defined in the methods section. These involved 8,970,811 
and 577,474 different people respectively. The median age of the patients was 61.0 in England 
and 62.0 in Wales; 55.0% and 56.0% respectively were female.  
 
Within one year of discharge from hospital, there were a total of 1,781 suicides in England (SMR 
= 1.7; 95% CI = 1.6-1.8) and 131 in Wales (SMR = 2.0; 1.7-2.3). The median age of the people 
who died from suicide was 56.0 in England and 53.0 in Wales and the percentages who were 
female were 30.2% and 28.2%, respectively. 
 
 
Suicide according to major physical illnesses 
For each of the 48 physical illnesses included in the study, Table 1 shows the numbers of 
admissions and summary patient demographic details in both countries. The 48 physical 
illnesses were largely gastrointestinal disorders (17), circulatory (eight) or respiratory diseases 
(six) which were associated with respectively 23.8%, 18.6% and 15.3% of the study suicides. 
For comparison, all gastrointestinal, circulatory and respiratory diseases accounted for 17.4%, 
20.4% and 13.9% of all acute admissions for physical illnesses (p<0.001 for this comparison).  
 
Table 2 shows the numbers of suicides, corresponding SMRs and summary demographics for 
the people who died from suicide. Three diseases had high suicide mortality (significant SMR 
>3) in both England and Wales and 11 had high suicide mortality in one but not both countries 
(Table 2). These were gastrointestinal disorders (six), endocrine, nutritional & metabolic 
diseases (three), diseases of the nervous system (two) and respiratory, genitourinary and 
musculoskeletal diseases (one each). None of the 48 diseases had significantly decreased SMRs. 
 
The three diseases with high suicide mortality in both countries were gastrointestinal 
disorders: constipation (SMR = 4.1 in England and 7.5 in Wales); gastritis (SMRs = 4.4 and 4.9 
respectively); and upper gastrointestinal bleeding (3.4 and 4.5). The suicide SMR of 3.5 for 
gastritis in England increased to 11.7 for cases confined to alcoholic gastritis. The three 
gastrointestinal diseases with high suicide mortality in one country were alcoholic liver disease 
(SMR = 4.8, England), other liver disease (5.6, England) and chronic pancreatitis (7.7, England). 
For each of these three disorders the corresponding SMRs were >3 in Wales although, with few 
suicides involved, none were significant.  
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Three endocrine, nutritional & metabolic diseases with high suicide risks in one country were 
diabetes (SMR = 5.5, Wales), hypoglycaemia (SMR = 3.7, England) and hypo-osmolality & 
hyponatraemia (SMR = 5.6, England).  
 
Two diseases of the nervous system with high suicide mortality in one country were epilepsy 
(SMR = 3.0, England) and Parkinson’s disease (SMR = 5.6, England). The SMR for epilepsy in 
Wales was also high (4.7) but marginally not significant. The remaining disorders with high 
suicide mortality in either country were pneumonia (SMR = 3.1, Wales), urinary tract infections 
(SMR = 3.5, Wales) and back pain (SMR = 3.9, Wales).  
 
When assessing suicide risks according to major disease grouping (ICD chapter) the highest 
SMRs were for endocrine, nutritional & metabolic diseases (SMR = 2.6, England and 3.9, Wales), 
diseases of the nervous system (2.2, England and 3.2, Wales) and gastrointestinal disorders (2.2, 
England and 2.4, Wales). More moderately increased suicide rates were apparent for cancers, 
circulatory, respiratory, genitourinary, skin, blood and musculoskeletal diseases, with no 
increased risk for infectious diseases.  
 
 
Suicide according to patient demographics 
Median ages at suicide were lowest following acute tonsillitis (35), orchitis and epididymitis 
(37), cutaneous abscess, furuncle & carbuncle (41), epilepsy (41.5), cellulitis (43.5), diabetes 
(45) and various gastrointestinal disorders, including acute appendicitis (37), chronic anal 
fissure (37), acute pancreatitis (39.5), chronic pancreatitis (44), other liver disease (45), and 
alcoholic liver disease (47.5; Table 2). Median ages at suicide were highest (>70 years) for 
Parkinson's disease and various circulatory or respiratory disorders including heart failure, 
stroke, atrial fibrillation, hypotension and acute lower respiratory infections. 
 
 
Suicides following admissions for constipation 
There were 49 suicides within one year of discharge with constipation (mean patient age = 65.6 
years; SD = 18.5). The majority (27; 55%) were aged 65+ years, 15 (31%) were 45-64 years, five 
(10%) were 25-44 years and one was <25 years. The underlying causes of death were hanging, 
strangulation or suffocation (20), self poisoning (12), drowning (6) and other forms of 
intentional or undetermined self harm (11). The most frequently recorded secondary or 
subsidiary causes of death (>5 cases) were asphyxia (20), drug poisoning (15), depression (9), 
multiple injuries (6) and cancers (5). The most frequently recorded co-morbidities on the index 
inpatient records were hypertension (9), depression (7), ischaemic heart disease (6), intestinal 
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diseases (6) followed by (<5 cases) asthma, personal history of psychoactive substance abuse, 
personal history of genitourinary or circulatory diseases, nausea and vomiting, retention of 
urine and hypercholesterolaemia.   
 
 
Sensitivity analysis 
A sensitivity analysis, confined to first study admissions for each patient, is summarised in a 
Supplementary Table for all physical illnesses with high significant SMRs >3. This shows little 
change in the study findings with no significant differences in SMRs.  
 
 
Influence of factors including pre-existing mental illness  
For most physical illnesses associated with high suicide risks, additional adjustment for pre-
existing mental illness had little or moderate influence on suicide odds ratios (<35% reduction; 
Table 3). However, there were larger reductions for alcoholic liver disease (55% reduction) and 
chronic pancreatitis (43%) in England. The prevalence of pre-existing mental illness was higher 
for alcoholic liver disease (67%) and chronic pancreatitis (43%) than for the other physical 
illnesses (<30%; Table 3). There was little additional confounding influence for social 
deprivation and year. 
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Discussion 
 
The study was designed to investigate all possible physical illnesses that may be associated with 
substantial suicide mortality, with very little or nothing previously reported on possible links 
with suicide for many of these illnesses. These include gastritis, chronic pancreatitis, upper 
gastrointestinal bleeding, acute tonsillitis, pleural effusion, hypoglycaemia and hypo-osmolality 
& hyponatraemia, so that many of the study findings are novel. 
 
The study found little or no increased suicide mortality following acute admissions for most of 
the 48 physical illnesses investigated. However, it found that most evidence of high suicide 
mortality (significant SMR >3) was, firstly, for gastrointestinal diseases that are often alcohol-
related (liver disease, chronic pancreatitis, gastritis and upper gastrointestinal bleeding) and 
other diseases that are sometimes alcohol-related (hypo-osmolality & hyponatraemia and 
pneumonia). Secondly, for conditions which are often caused by certain medications 
(constipation) or have suicide risks that are often linked to various therapeutic medications 
(epilepsy and Parkinson’s disease). Thirdly, for certain endocrine disorders that relate acutely 
to poor blood glucose control (diabetes and hypoglycaemia).  
 
There was a strong and consistent increased risk of suicide (four-fold in England and seven-fold 
in Wales) for patients discharged with constipation. Although this high suicide risk for 
constipation has not been quantified previously, severe constipation is common in people 
taking opioids or with opioid dependence and a known adverse effect for certain medications 
used for treating anaemia, epilepsy, pain, depression and other mental disorders. These 
medications include aluminium antacids (Talley et al. 2005), some antiepileptics (Jahromi et al. 
2011), iron and calcium supplements (Talley et al. 2005; Jahromi et al. 2011; Tolkien et al. 
2015), opiate analgesics (Talley et al. 2005; Benyamin et al. 2008; Camilleri, 2011; Rauck et al. 
2016), some antidepressants (Talley et al. 2005; Watanabe et al. 2010) and antipsychotics, 
particularly clozapine (De Hert  et al. 2011; Baptista et al. 2015; Shirazi et al. 2016). The link 
between these medications and disorders (some of which may be due to alcohol misuse or 
heavy alcohol consumption) associated with high risks of suicide may account for this 
association. 
 
We found evidence of an elevated suicide mortality of four to eight-fold for several 
gastrointestinal disorders that are either wholly or partially linked with alcohol misuse or heavy 
alcohol consumption, particularly among younger people. These disorders were gastritis, 
alcoholic liver disease, chronic pancreatitis and upper gastrointestinal bleeding. The suicide risk 
for gastritis in England was increased further (11.7 fold) for cases of alcoholic aetiology. A 
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previous cohort study reported 3.6 fold increased suicide mortality for liver disease overall 
(Erlangsen et al. 2015), although there have been no previous reports on suicide risks for 
gastritis, chronic pancreatitis or upper gastrointestinal bleeding. Links between suicide and 
both alcohol misuse disorder and heavy alcohol consumption are well established (Britton & 
McPherson, 2001; Wilcox et al. 2004; Schneider et al. 2011) with a recent meta analysis citing 
suicide SMRs of 9.8 and 3.5 respectively for these two disorders (Britton & McPherson, 2001). 
Alcohol consumption or misuse accounts for about 70% of cases of chronic pancreatitis and 
high minorities of both gastritis and upper gastrointestinal bleeding cases, the latter in 
particular through bleeds caused by varices, Mallory-Weiss tear, gastritis and oesophageal 
cancer (Williams et al. 2007). The high SMR for other liver disease may also involve some cases 
that were alcohol related but not recorded. As well as a strong link between alcohol misuse and 
suicide, attempted suicides have also been documented occasionally in case reports of gastritis 
(Wu et al. 2001; Descatha et al. 2009), pancreatitis (Hantson & Mahieu, 2000) and upper 
gastrointestinal bleeding (Altay et al. 2012; Zhao et al. 2010), disorders that can each arise 
through complications of medicinal intoxication or poisoning during suicide attempts. 
 
There was evidence of high suicide mortality for several major endocrine or metabolic diseases; 
diabetes, hypoglycaemia, and hypo-osmolality & hyponatraemia. Suicide mortality was 
increased 5.5-fold for diabetes in Wales and 2.3 fold in England. Previous disease register 
studies of type I diabetes from Scandinavia have cited suicide SMRs of 2.0 (Wibell et al. 2001), 
and 1.6 (Kyvik et al. 1994), while an English study of hospitalised diabetes among young people 
reported a much higher SMR of 11.7 (Roberts et al. 2004). Our more intermediate SMRs of 5.5 
and 2.3 would be increased through being based on hospitalised cases, but would be decreased 
through including type 2 with type 1 diabetes. Suicide risks in diabetes are inter linked with 
depression, poor compliance with diabetes treatment and blood glucose control (Lustman et al. 
2000; Sarkar & Balhara, 2014) which would explain some of the selection effects towards higher 
suicide mortality in studies based on inpatient cases. It would also partly explain our high 
suicide rate for hypoglycaemia (3.7 in England). We also found high suicide mortality (SMR = 
5.6 in England) for hypo-osmolality & hyponatraemia which has not been reported previously, 
can cause acute confusional states and may also be linked to cases of alcoholic aetiology. 
  
We found high suicide mortality in England for two diseases of the nervous system; epilepsy 
and Parkinson’s disease. There are well established links with suicide and co-morbid depression 
for both epilepsy (Hawton et al. 1980; Bell et al. 2009; Singhal et al. 2014; Erlangsen et al. 2015) 
and Parkinson’s disease (Erlangsen et al. 2015). For epilepsy, a recent meta analysis reported a 
suicide SMR of 3.3 (Bell et al. 2009) which is consistent with our SMRs of 3.0 in England and 4.7 
in Wales. For both Parkinson’s disease and epilepsy, treatments including various drugs (Bell et 
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al. 2009; Andersohn F et al. 2010), and deep brain simulation (Krack et al. 2003; Appleby et al. 
2007), have been associated with increased risks of suicide, although the evidence is often quite 
weak and conflicting. 
 
There was little or no evidence of substantially increased suicide mortality in the year following 
admission for most circulatory and respiratory diseases, with the exception of pneumonia in 
Wales (SMR = 3.1) although the SMR was 1.4 in England. There is little literature on an 
association between pneumonia and suicide, although excessive and prolonged use of alcohol is 
linked with increased hospital admissions for pneumonia (Kornum et al. 2012) while increased 
suicides have also been reported following hospitalisation with various infections (Lund-
Sørensen et al. 2016). Suggested mechanisms for the links between infections and suicide 
include proinflammatory cytokines, inflammatory metabolites and effects of antibiotic 
treatments on the biome (Lund-Sørensen et al. 2016). Some studies have found evidence of 
increased suicide risks for both cardiovascular and cerebrovascular diseases, but effect sizes are 
variable and often small or not significantly increased (Placido et al. 2009; Larsen et al. 2010; 
Webb et al. 2012; Pompili  et al. 2012; Crump et al. 2014; Singhal et al. 2014; Erlangsen et al. 
2015). Another study reported low suicide risks in a cohort of inpatients with acute general 
physical disorders (Olfson et al. 2016). We also found high suicide mortality for urinary tract 
infections in Wales (SMR = 3.5) but not in England (1.3). There are reported links between 
suicide and interstitial cystitis and bladder pain syndrome (Ratner, 2001; Hepner et al. 2012).  
 
We found modest increased SMRs for cancers (2.0 in both England and Wales) which are 
comparable or slightly higher than those from large disease register studies in England (1.7; 
Robinson et al. 2009), Sweden (1.5; Bjorkenstam et al. 2005), Norway (1.6; Hem et al. 2004), 
Denmark (1.7; Yousaf et al. 2005), Italy (1.5; Crocetti et al. 2012), and Austria (1.2; Vyssoki et al. 
2015). 
 
For most physical illnesses with high suicide mortality, there was moderate or little reduction in 
suicides (<35%) after additional adjustment for pre-existing mental illness and also low 
prevalence of mental illness (<30%). Although our case-ascertainment of pre-existing mental 
illness from secondary diagnoses in acute national inpatient data is incomplete, the findings 
indicate that subsequent suicides are largely independent of mental illness for physical illnesses 
with low mental illness prevalence. However, the two physical illnesses with high suicide risks 
that were most strongly mediated by pre-existing mental illness were alcoholic liver disease 
(55% reduction in risk) and chronic pancreatitis (43%). These two illnesses had by far the 
highest recorded prevalence of mental illness, largely mental and behavioural disorders through 
psychoactive substance use, mainly alcohol.  
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Major strengths are that this is one of the largest population studies of suicide after discharge 
from hospital, based on more than 1900 suicides among a total hospitalised population of 
almost 12 million people. It provides large-scale evidence on suicide risks for all major physical 
illnesses, which were associated with at least eight suicides, including many conditions that 
have not been reported previously. Importantly for confirmatory purposes, it is based on two 
independently collected information sources. It is also based on validated record linkage 
methodology that has been used extensively in previous follow-up mortality studies, which 
systematically identifies all deaths following discharge from hospital through national death 
certificate data. Although the inpatient data sources are confined to public hospitals, these 
account for almost all acute admissions. When assessing increased suicide risks for physical 
illnesses, odds ratios obtained through logistic regression modelling were typically lower 
(although not significantly so) than corresponding suicide SMRs, as they measure increased 
suicide risks with respect to different comparative reference points. SMRs are used more 
routinely to highlight increased risks of suicide (especially by government agencies) but do not 
readily facilitate adjustment for the additional factors assessed in this study, such as pre-
existing mental illness. 
 
Study limitations are that the national administrative inpatient data lacks detailed information 
about therapeutic treatment and prescribed medications as well as details of disease history 
and severity, while the principal diagnosis used to identify physical diseases is not accurate in 
all cases (Capital, 2014). Further, the diagnostic categories used for the different physical 
illnesses are constrained by the limitations of ICD coding. For example, when studying diabetes 
mellitus, we were not able to distinguish type 1 from type 2 diabetes in most cases. The 
definition of physical illness used here is based on acute admission so excludes people with 
more mild conditions that might appear in studies based on primary care data, disease registers, 
general population cohorts, outpatient or elective admissions. However, by restricting the study 
to acute admissions, it excludes a large volume of elective admissions that are often for 
diagnostic investigations rather than for active or present disease (Li & Rothwell, 2016). There 
was also much less study power in Wales than in England. 
 
Despite these limitations, the sizes of the populations studied and the consistency of the 
findings across the two countries suggests that the study findings are valid and highlight 
potential opportunities for suicide prevention. Associations between physical illnesses and 
suicide can be mediated in some cases by mental illnesses, which we investigated by measuring 
pre-existing mental illnesses based on diagnoses recorded in patients' current or previous acute 
admissions. As mental illnesses are often not recorded comprehensively as secondary diagnoses 
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in this inpatient data, further research should focus on more in-depth, smaller-scale studies that 
incorporate full mental health or primary care diagnostic data, to establish the complex 
relationships between physical illnesses, mental illnesses and the subsequent risks of suicide. 
 
 
Preventative measures and policy implications 
A recent large record linkage study of general and psychiatric hospital discharge across the UK 
(Dougall et al. 2014), found that those who died by suicide were 3.1 times more frequently 
discharged from general rather than psychiatric hospitals. While this study highlighted that 
engaging in suicide prevention within the general hospital setting deserves more attention, 
other than for self harm, it provided little evidence for where these efforts should be focussed. 
Delivering effective universal suicide prevention in this setting is a challenge given the large 
numbers of individuals admitted, the small number who will take their own lives and the range 
of specialties from which they are discharged. A more appropriate universal intervention could 
be on raising awareness of mental health issues in this setting. Selective interventions aimed at 
those discharged following acute hospital admissions can be considered to be a more focussed 
opportunity for intervention than for all admissions. Absolute risks of suicide are very low for 
almost all physical illnesses, which have major cost-effectiveness implications for potential 
interventions. Nonetheless, efforts targeted carefully at those discharged with constipation, 
some alcohol-related gastrointestinal and metabolic disorders, epilepsy and Parkinson's disease 
may yield the most benefits. 
 
The types of activities that might reduce the risk of suicide include: raising awareness of  
suicidal behaviours to healthcare staff through education and training; ensuring that questions 
relating to mental health are asked and any suicidal ideation is elicited; improving 
communication of these issues between clinicians at the interface between primary and 
secondary care, between different specialities and at any outpatient appointments; 
improvements in psychiatric liaison services in general hospital settings; appropriate 
signposting to organisations offering support for particular conditions and/or for suicidal 
ideation and behaviours; and finally promoting social support by family members, carers or 
friends if appropriate. 
 
 
Conclusions 
In summary, we found that emergency hospitalisations for most physical diseases usually lead 
to small or no increased risks of suicide in the year following discharge from hospital. However, 
for certain conditions, there is evidence of substantially increased risks of suicide. This is the 
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case for several alcohol-related gastrointestinal disorders, some metabolic disorders, epilepsy, 
Parkinson's disease, constipation and a few other disorders. NICE currently recommends 
psychosocial assessment for people admitted to general hospitals for self harm. Further 
evidence is needed to determine the potential of psychosocial assessment for people admitted 
with alcohol and other high-risk conditions. At the very least for those conditions with high 
associated risks of suicide, healthcare staff should ensure they ask those admitted as 
emergencies questions relating to their mental health and whether they have any thoughts of 
suicide. 
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Table 1 Numbers of admissions and summary patient demographics for people hospitalised as  
emergencies for physical illnesses across England and Wales 
 
  
England  
 
Wales 
 
 
 
Physical illness * 
No. of 
admissions 
 
Mean  
(and median)  
age at admission 
 
 
% 
female 
 
No. of 
admissions 
 
Mean  
(and median)  
age at admission 
 
 
%  
female 
         
Infectious & parasitic diseases 284 174 50.0     (49.0) 52.2%  17 272 54.3     (53.0) 55.0% 
   - Septicaemia 42 747 67.2     (71.0) 51.7%  3260 67.6     (70.0) 54.8% 
         
Endocrine  nutritional & metabolic diseases 279 099 60.0     (64.0) 51.6%  18 347 60.7     (65.0) 52.2% 
   - Diabetes mellitus 121 531 52.5     (53.0) 41.8%  8509 54.3     (56.0) 43.3% 
   - Hypoglycaemia 32 486 66.6     (72.0) 49.0%  2088 66.6     (72.0) 50.1% 
   - Hypo-osmolality & hyponatraemia 23 897 75.1     (78.0) 71.5%  1371 75.3     (79.0) 72.8% 
        
Cancers 459 021 68.0     (70.0) 48.3%  31 267 69.4     (71.0) 47.3% 
   - Gastrointestinal cancers 118 641 70.1     (72.0) 43.7%  8640 71.5     (73.0) 43.9% 
   - Lung cancer 65 334 70.3     (71.0) 43.7%  4833 70.6     (71.0) 43.0% 
   - Lymphomas 58 551 63.8     (66.0) 43.9%  3311 65.3     (68.0) 43.7% 
        
Disease of the nervous system 443 852 57.7     (59.0) 53.6%  29 206 56.9     (62.0) 53.4% 
   - Parkinson's disease 15 997 76.5     (78.0) 38.9%  1321 77.0     (78.0) 43.4% 
   - Epilepsy 104 316 47.8     (45.0) 44.3%  5845 48.8     (47.0) 46.0% 
   - Transient ischaemic attack 117 949 72.0     (74.0) 50.1%  6756 71.0     (74.0) 48.0% 
        
Circulatory diseases 2 247 914 68.4     (71.0) 44.5%  145 660 69.1     (71.0) 45.4% 
   - Ischaemic heart disease 765 742 67.5     (68.0) 37.1%  49 508 68.3     (69.0) 38.5% 
   - Stroke 337 752 73.1     (76.0) 48.7%  21 041 73.4     (76.0) 48.6% 
   - Pulmonary embolism 87 602 63.5     (66.0) 52.6%  5079 63.0     (66.0) 52.5% 
   - Atrial fibrillation 274 179 69.7     (72.0) 49.3%  19 050 70.2     (72.0) 50.2% 
   - Heart failure 170 924 77.6     (79.0) 49.1%  12 223 77.4     (79.0) 49.2% 
   - Phlebitis & thrombophlebitis 115 605 60.6     (63.0) 50.2%  4879 62.1     (64.0) 51.5% 
   - Haemorrhoids 35 192 49.7     (46.0) 40.8%  2796 50.5     (48.0) 40.6% 
    - Hypotension 57 460 77.4     (80.0) 54.5%  3794 76.7     (79.0) 54.2% 
        
Respiratory diseases 1 530 397 61.2     (66.0) 52.3%  105 950 62.4     (67.0) 53.3% 
   - Pneumonia 396 821 66.7     (71.0) 49.1%  25 488 66.1     (70.0) 49.4% 
   - Acute lower respiratory infections 289 857 66.4     (72.0) 55.1%  22 236 66.8     (72.0) 55.6% 
   - COPD 326 051 71.1     (72.0) 51.2%  25 273 71.1     (72.0) 52.0% 
   - Asthma 177 629 47.4     (45.0) 65.9%  10 911 49.5     (48.0) 68.8% 
   - Acute tonsillitis 57 472 29.5     (27.0) 53.5%  3862 29.3     (26.0) 55.4% 
   - Pleural effusion 46 274 69.0     (72.0) 44.8%  2698 70.0     (72.0) 44.2% 
         
Gastrointestinal diseases 1 918 700 55.6     (56.0) 52.0%  130 016 56.6     (58.0) 53.2% 
   - Gastro-oesophageal reflux disease 46 786 59.3     (60.0) 50.2%  3808 58.9     (60.0) 50.5% 
   - Peptic ulcer 75 321 63.7     (67.0) 40.1%  4305 64.3     (68.0) 41.2% 
   - Gastritis 71 561 52.6     (51.0) 50.3%  5872 53.2     (53.0) 50.7% 
   - Acute appendicitis 156 380 37.5     (34.0) 44.0%  8733 37.3     (34.0) 41.9% 
   - Herniae 85 714 61.6     (64.0) 40.9%  6119 61.9     (64.0) 40.3% 
   - Noninfective gastroenteritis 209 855 56.2     (58.0) 60.3%  13 943 57.4     (60.0) 61.0% 
   - Intestinal obstruction 69 249 65.2     (68.0) 53.6%  3969 65.7     (68.0) 54.1% 
   - Diverticular disease 99 882 66.7     (68.0) 61.4%  7782 66.9     (68.0) 
  ) 
62.6% 
   - Alcoholic liver disease 31 347 51.4     (51.0) 35.0%  2535 52.1     (52.0) 34.8% 
   - Other liver disease 22 200 57.2     (59.0) 48.7%  1479 59.4     (61.0) 48.6% 
   - Gallstone disease 233 627 57.0     (58.0) 67.5%  19 326 57.2     (59.0) 67.9% 
   - Acute pancreatitis 68 649 55.5     (56.0) 47.5%  4197 56.9     (58.0) 46.8% 
   - Chronic pancreatitis 11 716 47.6     (46.0) 28.6%  833 48.5     (48.0) 27.4% 
%    - Upper gastrointestinal bleeding 134 706 59.3     (62.0) 42.0%  7988 60.0     (63.0) 40.8% 
   - Constipation 115 470 63.1     (68.0) 60.1%  9139 61.9     (68.0) 60.9% 
   - Chronic anal fissure 67 090 41.4     (40.0) 29.2%  4085 42.6     (41.0) 30.6% 
   - Anal haemorrhage 63 386 63.3     (68.0) 52.0%  1703 63.8     (68.0) 51.8% 
        
Skin diseases 558 074 51.9     (50.0) 45.6%  33 158 52.9     (52.0) 46.1% 
   - Cellulitis 252 877 59.5     (60.0) 45.8%  15 405 59.6     (61.0) 45.0% 
   - Cutaneous abscess, furuncle & carbuncle 129 863 42.0     (39.0) 45.2%  6536 43.0     (40.0) 46.9% 
        
Musculoskeletal diseases 877 248 59.0     (60.0) 57.3%  47 243 59.4     (61.0] 56.8% 
   - Back pain 179 564 52.1     (49.0) 56.6%  10 053 53.2     (51.0) 56.8% 
5         
Genitourinary diseases 1 172 753 53.9     (51.0) 59.9%  74 484 53.8     (52.0) 61.7% 
   - Acute renal failure 58 879 72.4     (76.0) 44.5%  3255 72.6     (76.0) 45.2% 
   - Urinary tract infections 399 831 68.4     (77.0) 68.3%  26 004 65.8     (74.0) 69.8% 
   - Orchitis & epididymitis 38 399 42.3     (39.0) 0%  3143 41.5     (38.0) 0% 
        
Diseases of the blood 180 963 64.2     (69.0) 62.0%  11 693 67.5     (71.0) 62.8% 
   - Anaemias 134 796 66.9     (73.0) 62.7%  8796 70.7     (75.0) 63.0% 
        
All physical illnesses  11 004 389 57.9     (61.0) 55.0%  713 496 58.4     (62.0) 56.0% 
 
Notes 
 
      
  *   Includes illnesses which led to at least eight suicides within one year of discharge from hospital   
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Table 2 Numbers of admissions and suicides with corresponding SMRs and summary patient demographics for people who died from suicide after 
discharge from hospital with physical illnesses across England and Wales 
 
 
 
 England  Wales 
Physical illness  ‡ 
 
 
No. of 
admissions 
 
No. of 
suicides at 
one year † 
 
 
 
SMR 
 
 
 
(95% CI) 
 
Mean  
(and median) 
age at suicide  
 
 
% 
female 
 
No. of 
admissions 
No. of 
suicides at 
one year † SMR (95% CI) 
 
Mean  
(and median) 
age at suicide 
 
 
% 
female 
 
      
 
          
Infectious & parasitic diseases  284 174 36 1.3 (0.9-1.7) 48.1    (41.0) 28%  17 274 * 1.2 (0.1-3.5) * * 
   - Septicaemia 42 747 8 1.9 (0.8-3.5) 60.8    (65.5) 25%  3260 * 3.3 (0.0-13.0) * * 
 
             
Endocrine, nutritional & metabolic diseases 279 099 71 2.6 (2.0-3.2) 52.9    (52.0) 35%  18 347 7 3.9 (1.6-7.4) 46.1    (47.0) 0% 
   - Diabetes mellitus 121 531 31 2.3 (1.6-3.2) 47.8    (45.0) 32%  8509 5 5.5 (1.7-11.4) 46.6    (47.0) 0% 
   - Hypoglycaemia 32 486 12 3.7 (1.9-6.2) 56.9    (55.5) 42%  2088 * 4.9 (0.0-19.2) * * 
   - Hypo-osmolality & hyponatraemia 23 897 10 5.6 (2.5-9.9) 66.9    (68.5) 30%  1371 0 0  * * 
 
             
Cancers 459 021 87 2.0 (1.6-2.4) 67.4    (68.0) 17%  31 267 6 2.0 (0.7-3.9) 75.5    (75.0) 0% 
   - Gastrointestinal cancers 118 641 24 2.0 (1.3-3.0) 66.5    (68.0) 4%  8640 * 2.4 (0.2-6.8) * * 
   - Lung cancer 65 334 15 2.4 (1.3-3.7) 69.5    (68.0) 20%  4833 * 2.2 (0.0-8.5 * * 
   - Lymphomas 58 551 15 2.5 (1.4-3.9) 67.6    (69.0) 13%  3300 * 0  * * 
 
             
Disease of the nervous system 443 852 98 2.2 (1.8-2.7) 54.2    (54.0) 38%  29 206 9 3.2 (1.4-5.6) 51.9   (47.0) 33% 
   - Parkinson's disease 15 997 9 5.6 (2.5-9.9) 70.3    (71.0) 22%  1321 0 0  * * 
   - Epilepsy 104 316 30 3.0 (2.0-4.1) 42.2    (41.5) 43%  5845 * 4.7 (0.9-11.3) * * 
   - Transient ischaemic attack 117 949 15 1.5 (0.9-2.4) 65.2    (67.0) 27%  6756 * 3.1 (0.3-8.9) * * 
 
             
Circulatory diseases 2 247 914 335 1.4 (1.3-1.6) 64.2    (65.0) 25%  145 660 20 1.4 (0.8-2.0) 60.9    (63.5) 30% 
   - Ischaemic heart disease 765 742 107 1.3 (1.0-1.5) 64.1    (63.0) 17%  49 508 * 0.4 (0.0-1.1) * * 
   - Stroke 337 752 50 1.5 (1.0-2.0) 68.9    (70.0) 22%  21 041 5 2.5 (0.8-5.2) 73.4    (71.0) 0%  
(8.1)    - Pulmonary embolism 87 602 15 1.8 (1.0-2.8) 51.3    (55.0) 33%  5079 0 0  * * 
   - Atrial fibrillation 274 179 35 1.3 (0.9-1.8) 72.7    (74.0) 31%  19 050 * 1.6 (0.3-4.0) * * 
   - Heart failure 170 924 18 1.1 (0.7-1.7) 76.9    (79.0) 33%  12 223 * 0.8 (0.0-3.4) * * 
   - Phlebitis & thrombophlebitis 115 605 19 1.6 (1.0-2.4) 50.2    (50.0) 16%  4879 * 2.0 (0.0-8.0) * * 
   - Haemorrhoids 35 192 9 2.1 (0.9-3.7) 54.0    (53.0) 22%  2796 0 0  * * 
   - Hypotension 57 460 15 2.9 (1.6-4.5) 71.0    (77.0) 47%  3794 * 2.9 (0.0-11.5) * * 
 
             
Respiratory diseases 1 530 397 273 2.0 (1.7-2.2) 61.5    (63.0) 33%  105 950 20 2.0 (1.3-3.0) 56.0   (56.5) 20% 
   - Pneumonia 396 821 54 1.4 (1.1-1.8) 61.8    (61.0) 28%  25 488 8 3.1 (1.3-5.7) 63.9   (67.0) 38% 
   - Acute lower respiratory infections 289 857 42 1.5 (1.1-2.0) 65.9    (71.5) 31%  22 236 * 1.0 (0.1-2.7) * * 
   - COPD 326 051 79 2.8 (2.2-3.5) 68.0    (68.0) 42%  25 273 * 1.8 (0.5-3.9) * * 
   - Asthma 177 629 21 1.3 (0.8-2.0) 48.8    (48.0) 43%  10 911 0 2.2 (0.2-6.2) * * 
   - Acute tonsillitis 57 472 11 2.1 (1.0-3.4) 34.1    (35.0) 18%  3862 * 2.9 (0.0-11.4) * * 
   - Pleural effusion 46 274 13 2.8 (1.5-4.5) 72.5    (69.0) 8%  2698 0 0  * * 
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 England  Wales 
Physical illness  ‡ 
 
 
No. of 
admissions 
 
No. of 
suicides at 
one year † 
 
 
 
SMR 
 
 
 
(95% CI) 
 
Mean  
(and median) 
age at suicide 
 
 
%  
female 
 
No. of 
admissions 
No. of 
suicides at 
one year † SMR (95% CI) 
 
Mean  
(and median)  
age at suicide 
 
 
% 
female 
 
             
Gastrointestinal diseases 1  918 700 425 2.2 (2.0-2.4) 53.6    (52.0) 28%  130 016 31 2.4 (1.6-3.3) 48.7    (42.0) 29% 
   - Gastro-oesophageal reflux disease 46 786 11 2.2 (1.1-3.7) 53.2    (57.0) 46%  3808 0 0  * * 
   - Peptic ulcer 75 321 13 1.4 (0.7-2.4) 56.8    (56.0) 8%  4305 0 0  * * 
   - Gastritis 71 559 33 4.4 (3.0-6.0) 50.0    (49.0) 24%  5872 * 4.9 (1.0-12.4) * * 
   - Acute appendicitis 156 380 17 1.0 (0.6-1.5) 37.1    (37.0) 18%  8733 * 2.1 (0.2-6.0) * * 
   - Herniae 85 714 17 1.8 (1.0-2.7) 60.8    (62.0) 6%  6119 * 2.9 (0.3-8.4) * * 
   - Noninfective gastroenteritis 209 855 42 2.2 (1.6-2.9) 55.9    (51.5) 48%  13 943 * 0.8 (0.0-3.1) * * 
   - Intestinal obstruction 69 249 11 1.7 (0.8-2.8) 66.8    (65.0) 36%  3969 0 0  * * 
   - Diverticular disease 99 882 20 2.2 (1.3-3.3) 62.0    (63.5) 50%  7782 * 2.9 (0.3-8.3) * * 
   - Alcoholic liver disease 31 347 20 4.8 (2.9-7.1) 46.4    (47.5) 10%  2535 * 6.0 (0.6-17.2) * * 
   - Other liver disease 22 200 13 5.6 (3.0-9.0) 43.0    (45.0) 23%  1479 * 6.6 (0.0-25.8) * * 
   - Gallstone disease 233 627 16 0.8 (0.5-1.3) 56.1    (60.0) 63%  19 326 0 0  * * 
   - Acute pancreatitis 68 649 18 2.4 (1.4-3.6) 45.3    (39.5) 33%  4197 * 4.3 (0.4-12.5) * * 
   - Chronic pancreatitis 11 716 13 7.7 (4.1-12.4) 43.5    (44.0) 8%  833 * 8.3 (0.0-32.4) * * 
   - Upper gastrointestinal bleeding  134 706 52 3.4 (2.5-4.4) 49.3    (48.0) 16%  7988 * 4.5 (1.2-10.0) * * 
   - Constipation 115 470 43 4.1 (2.9-5.4) 66.1    (68.0) 33%  9139 6 7.5 (2.7-14.2) 62.2    (65.5) 67% 
   - Chronic anal fissure 67 090 10 1.1 (0.5-1.8) 36.4    (37.0) 10%  4085 * 1.8 (0.0-7.0) * * 
   - Anal haemorrhage 63 386 13 2.1 (1.1-3.4) 61.7    (59.0) 23%  1703 0 0  * * 
 
             
Skin diseases 558 074 96 1.5 (1.3-1.9) 48.7    (44.0) 23%  33 158 9 2.5 (1.1-4.4) 57.0    (51.0) 22% 
   - Cellulitis 252 877 46 1.6 (1.2-2.2) 49.0    (43.5) 17%  15 405 * 2.3 (0.6-5.2) * * 
   - Cutaneous abscess, furuncle & carbuncle 129 863 29 1.9 (1.3-2.7) 42.8    (41.0) 21%  6536 * 4.1 (0.8-10.0) * * 
 
             
Musculoskeletal diseases 877 248 146 1.7 (1.5-2.0) 56.4    (54.0) 34%  47 243 9 2.0 (0.9-3.4) 53.0    (54.0) 33% 
   - Back pain 179 564 46 2.5 (1.8-3.3) 42.8    (49.0) 48%  10 053 * 3.9 (1.0-8.8) * * 
 
             
Genitourinary diseases 1 172 753 130 1.2 (1.0-1.4) 50.8    (45.0) 39%  74 484 15 2.3 (1.3-3.6) 56.0    (57.0) 47% 
   - Acute renal failure 58 879 10 1.7 (0.8-2.9) 59.4    (58.5) 30%  3255 * 3.1 (0.0-12.3) * * 
   - Urinary tract infections 399 831 41 1.3 (0.9-1.7) 58.2    (60.0) 54%  26 004 7 3.5 (1.4-6.5) 60.9    (64.0) 71% 
   - Orchitis & epididymitis 38 399 8 1.3 (0.5-2.3) 44.9    (37.0) 0%  3143 * 2.0 (0.0-7.7) * 0% 
 
             
Diseases of the blood  180 963 
647 
29 1.8 (1.2-2.6) 58.7    (54.0) 24%  11 693 * 2.0 (0.2-5.8) * * 
   - Anaemias 134 96 21 1.7 (1.1-2.6) 62.2    (57.0) 33%  8796 * 2.3 (0.3-7.8) * * 
 
             
All physical illnesses  11 004 389 1781 1.7 (1.6-1.8) 57.0    (56.0) 30%  713 496 131 2.0 (1.7-2.3) 55.1    (53.0) 28% 
 
 
Notes 
*    Denotes less than five suicides 
‡    Includes illnesses which led to at least eight suicides within one year of discharge from hospital 
†    Includes suicides or injury & poisoning of undetermined intent, recorded as the underlying cause of death 
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Table 3  Adjustment of suicide odds ratios for a). pre-existing mental illness, and b). pre-existing mental illness, calendar year and social deprivation  
  (as well as patient age and sex): for physical illnesses associated with high suicide risks in England or Wales 
 
 
 
 
 
 
 
  
 
Models 1 
(adjusted for patient  
age and sex)  
 
Models 2 
(adjusted for pre-existing 
mental illness, age and sex) 
 
 
  
 
Models 3  
(adjusted for pre-existing 
mental illness, year, social 
deprivation, age and sex) 
 
 
 
 
 
 
 
Physical illness   
 
  % of cases with  
   recorded 
  pre-existing     
   mental illness Odds ratio     (95% CI)  Odds ratio         (95% CI)   
 
% reduction  
in suicide  
odds ratio 
 (models 2 vs 1)  Odds ratio         (95% CI) 
% reduction  
in suicide  
odds ratio 
(models 3 vs 1) 
 
 
     
 
      England:     
     
 
   
  
           
   - Hypoglycaemia 11.5 2.27 (1.28, 4.00)  2.07 (1.17, 3.65) 8.8%  2.11 (1.20, 3.73)  7.0% 
   - Hypo-osmolality & hyponatraemia 18.6 3.42 (1.83, 6.37)  2.50 (1.34, 4.66) 26.9%  2.52 (1.32, 4.70)  26.3% 
                
   - Parkinson's disease 12.4 3.53 (1.83, 6.82)  2.82 (1.40, 5.66) 20.1%  2.41 (1.15, 5.07)  31.7% 
   - Epilepsy 27.5 1.78 (1.24, 2.56)  1.23 (0.86, 1.77) 30.9%  1.15 (0.79, 1.67)  35.4% 
                
   - Gastritis                                     17.1 2.63 (1.86,  3.71)  2.07 (1.46, 2.94) 21.3%  2.04 (1.43, 2.91)  22.4% 
   - Alcoholic liver disease 66.6 2.67 (1.72, 4.16)  1.19 (0.76, 1.87) 55.4%  1.16 (0.74, 1.81)  56.6% 
   - Other liver disease 15.3 3.20 (1.86, 5.53)  2.55 (1.45, 4.51) 20.3%  2.38 (1.31,  4.31)  25.6% 
   - Chronic pancreatitis 43.3 4.56 (2.64, 7.89)  2.60 (1.50, 4.51) 43.0%  2.59 (1.50, 4.49)  43.2% 
   - Upper gastrointestinal bleeding  18.8 2.11 (1.60, 2.79)  1.60 (1.21, 2.12) 24.2%  1.56 (1.17, 2.07)  26.1% 
   - Constipation 9.2 2.48 (1.83, 3.36)  2.43 (1.79, 3.29) 2.0%  2.47 (1.83, 3.35)  0.4% 
                
Wales:                
                
   - Diabetes mellitus 
 
10.3 2.68 (1.10, 6.58)  2.39 (0.97,  5.87) 10.8%  2.44 (1.00,  6.00)  9.0% 
               
   - Gastritis 13.9 2.39 (0.76, 7.51)  1.81 (0.57, 5.71) 24.2%  1.87 (0.59, 5.90)  21.8% 
   - Upper gastrointestinal bleeding  17.6 2.31 (0.85, 6.26)  1.51 (0.55, 4.13) 
 
34.6%  1.17 (0.37, 3.71)  49.4% 
   - Constipation 8.2 4.15 (1.83, 9.44)  4.07 (1.79, 9.27) 1.9%  4.11 (1.80, 9.43)  0.9% 
                
   - Pneumonia 10.5 1.74 (0.85,  3.58)  1.53 (0.75,  3.14) 12.1%  1.54 (0.75, 
3.55) 
3.16)  11.5% 
   - Back pain  5.4 1.93 (0.71, 5.23)  2.25 (0.83,  6.11) -16.6%  2.35 (0 8 ,
66 
6.26)  -21.8% 
   - Urinary tract infections 7.4 2.00 (0.93, 4.32)  1.97 (0.91,  4.26) 1.5%  1.97 (0.91,  4.28)  1.5% 
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 Appendix ICD-10 codes for the 48 physical illnesses included in the study 
 
 
 
Infectious & parasitic diseases A00-B99 
   - Septicaemia A40, A41 
  
Endocrine  nutritional & metabolic diseases E00-E90 
   - Diabetes mellitus E10-E14 
   - Hypoglycaemia E16.2 
   - Hypo-osmolality & hyponatraemia E87.1 
  
Cancers C00-C97 
   - Gastrointestinal cancers C15-C26 
   - Lung cancer C33, C34 
   - Lymphomas C81-C96 
  
Disease of the nervous system G00-G99 
   - Parkinson's disease G20 
   - Epilepsy G40, G41 
   - Transient ischaemic attack G45.9 
  
Circulatory diseases I00-I99 
   - Ischaemic heart disease I20-I25 
   - Stroke I61-I64 
   - Pulmonary embolism I26 
   - Atrial fibrillation I48 
   - Heart failure I50 
   - Phlebitis & thrombophlebitis I80 
   - Haemorrhoids I84 
   - Hypotension I95 
  
Respiratory diseases J00-J99 
   - Pneumonia J12-J18 
   - Acute lower respiratory infections J20-J22 
   - COPD J40-J44 
   - Asthma J45, J46 
   - Acute tonsillitis J03 
   - Pleural effusion J90 
  
Gastrointestinal diseases K00-K93 
   - Gastro-oesophageal reflux disease K21 
   - Peptic ulcer K25-K28 
   - Gastritis K29.0-K29.7 
   - Acute appendicitis K35 
   - Herniae K40-K43, K45, K46 
   - Noninfective gastroenteritis K52 
   - Intestinal obstruction K56 
   - Diverticular disease K57 
   - Alcoholic liver disease K70 
   - Other liver disease K71-K77 
   - Gallstone disease K80 
   - Acute pancreatitis K85 
   - Chronic pancreatitis K86.0, K86.1 
   - Upper gastrointestinal bleeding I85.0,K22.6,K22.8,K25.0,K25.2,K25.4,K25.6,K26.0,K26.2,K26.4,K26.6,K27.0 
 K27.2,K27.4,K27.6,K28.0,K28.2,K28.4,K28.6,K29.0,K92.0,K92.1,K92.2* 
   - Constipation K59 
   - Chronic anal fissure K61.0 
   - Anal haemorrhage K62.5 
  
Skin diseases L00-L99 
   - Cellulitis L03 
   - Cutaneous abscess, furuncle & carbuncle L02 
  
Musculoskeletal diseases M00-M99 
   - Back pain M54 
  
Genitourinary diseases N00-N99 
   - Acute renal failure N17 
   - Urinary tract infections N39.0 
   - Orchitis & epididymitis N45 
  
Diseases of the blood D50-D99 
   - Anaemias D50-D64 
  
All physical diseases  A00-E99, G00-Q99 
  
*   Unless present with a diagnosis of lower gastrointestinal disease (C17.1-C21, K50-K52, K55-K57 or K60-K63) 
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Appendix cont’d  Mental and behavioural disorders (with ICD-10 codes) used to measure 
pre-existing mental illness 
 
 
Mental and behavioural disorders due to psychoactive substance use F10-F19 
Schizophrenia, schizotypal and delusional disorders F20-F29 
Mood (affective) disorders F30-F39 
Neurotic, stress-related and somatoform disorders F40-F49 
Disorders of adult personality and behaviour F60-F69 
Mental retardation F70-F79 
Disorders of psychological development F80-F89 
Behavioural and emotional disorders with onset that usually occurs in childhood and adolescence F90-F99 
 
 
 
